Type 2 diabetes, definitions combined, including avohilmo

PheWeb

T2D_INCLAVO

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions

not E4_DM1

312402

Filter registries

Primary healthcare outpatient ICD-10: E11

32893

Check pre-conditions, main-only, mode, ICD version None

32893

Check minimum number of events None

32893

Include endpoints

T2D_WIDE

E4_DM2

48470

T2D_INCLAVO

Extra metadata

First used in FinnGen datafreeze DF5

Similar endpoints

↥

List of similar endpoints to Type 2 diabetes, definitions combined, including avohilmo based on the number of shared cases.

Broader endpoints:

None

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	46818	21185	25633
Unadjusted prevalence (%)	15.17	12.21	18.98
Mean age at first event (years)	60.52	59.58	61.29

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.03	2.36 [2.14, 2.61]	3.6e-63	6951
15 years	0.01	1.57 [1.43, 1.71]	1.8e-22	3517
5 years	0.00	2.49 [2.29, 2.71]	<1e-100	1853
1 year	0.00	4.42 [3.88, 5.03]	<1e-100	633

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: T2D_INCLAVO – Type 2 diabetes, definitions combined, including avohilmo
GWS hits: 109

Survival analyses between endpoints

↥

Plot

before Type 2 diabetes, definitions combined, including avohilmo
after Type 2 diabetes, definitions combined, including avohilmo

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Type 2 diabetes, definitions combined, including avohilmo

↥